Arcturus Therapeutics (ARCT) - Net earnings per share (EPS TTM)

Symbol and logo of brand arcturusrx.com (ARCT)

Arcturus Therapeutics (ARCT) is based on mRNA delivery patents, creating a foundation for monetization. The company adheres to trial ethics and biosafety standards within the ESG framework. Royalties from COVID-19 vaccine sales are driving current growth. This chart illustrates the rolling annual income per share calculated by the GURU.Markets system, where the -3.06 indicator determines the parameter status.

ARCT (arcturusrx.com) Earnings per share for the last 12 months history from 07/04/2022 to 11/15/2026

Comprehensive metric breakdowns and analytics for Arcturus Pharma (ARCT)

General company analysis:arcturusrx.com (ARCT)
Mass-produced product of Arcturus Therapeutics Inc

Amidst a fierce battle for RNA patents against biotech giants, the financial stability of Arcturus Therapeutics (ARCT) depends directly on its ability to generate real revenue. By analyzing the trailing twelve-month earnings per share, an investor assesses the net operating result stripped of dilution pressure, which allows for the identification of capital freeze risks through the dynamics of earnings per share.

Competitors of Arcturus Therapeutics (ARCT)

VRTX: Net earnings per share for the last 12 months|Earnings per one share for the last 12 months ALNY|INSM: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months United Therapeutics Corp. (UTHR)|BMRN (BioMarin) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months BBIO (BridgeBio)|Earnings per share for the last twelve months bgm.ltd (BGM)|COGT (Cogent Biosciences Inc) - Earnings per share for the trailing year|Earnings per share for the last twelve months Xeris Biopharma Holdings XERS|KROS (Keros Pharma) - Earnings per one share for the last 12 months|Eton Pharmaceuticals - Net earnings per share (EPS TTM)|Earnings per share for the trailing year KMDA (Kamada Ltd.)|FULC: Net earnings per share (EPS TTM)|Abeona (ABEO) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months mereobiopharma.com|Net earnings per share for the last 12 months Protalix (PLX)|Earnings per share for the last twelve months Pliant Therapeutics Inc (PLRX)|Net earnings per share for the last 12 months Applied Therapeutics, Inc. APLT|Net earnings per share (EPS TTM) RNTX (aileronrx.com)|Net earnings per share (EPS TTM) Gelteq Limited Inc GELS|Aytu BioPharma, Inc. - Net earnings per share (EPS TTM)|chemomab.com (CMMB) - Net earnings per share for the last 12 months|SRx Health (SRXH) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Polyrizon Ltd. (PLRZ)|Net earnings per share for the last 12 months AEZS|Net earnings per share for the last 12 months Cyclo Therapeutics Inc. (CYTH)|Net earnings per share for the last 12 months INZY (inozyme.com)|RPHM - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) CSCI (cosciensbio.com)